Biliary cystadenoma and cystadenocarcinoma other diagnostic studies

Biliary cystadenoma and cystadenocarcinoma Microchapters
Home
Patient information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Biliary cystadenoma and cystadenocarcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Biliary cystadenoma and cystadenocarcinoma other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Biliary cystadenoma and cystadenocarcinoma other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Biliary cystadenoma and cystadenocarcinoma other diagnostic studies
CDC on Biliary cystadenoma and cystadenocarcinoma other diagnostic studies
Biliary cystadenoma and cystadenocarcinoma other diagnostic studies in the news
Blogs on Biliary cystadenoma and cystadenocarcinoma other diagnostic studies
Directions to Hospitals Treating Biliary cystadenoma and cystadenocarcinoma
Risk calculators and risk factors for Biliary cystadenoma and cystadenocarcinoma other diagnostic studies

Overview

Elevated CEA and CA 19-9 in the serum or the cystic fluid aids in diagnosis and followup of patients [16, 36]. A normal level does not exclude a biliary cystadenoma; some simple liver cysts may also show elevated serum or cystic fluid CEA or CA 19-9.